- Release Date: 28/04/25 08:32
- Summary: FDA confirms Proteinuria as Primary Endpoint for US approval
- Price Sensitive: Yes
- Download Document 359.86KB
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
58.5¢ |
Change
-0.005(0.85%) |
Mkt cap ! $339.3M | |||
| Open | High | Low | Value | Volume |
| 59.5¢ | 60.5¢ | 57.5¢ | $1.229M | 2.081M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 130185 | 58.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 7685 | 2 |
View Market Depth
| Last trade - 16.10pm 22/05/2025 (20 minute delay) ? |
| DXB (ASX) Chart |